Astrazeneca Phar

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE203A01020
  • NSEID: ASTRAZEN
  • BSEID: 506820
INR
9,115.00
-73.9 (-0.8%)
BSENSE

Dec 05

BSE+NSE Vol: 987

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 777011,
    "name": "Astrazeneca Phar",
    "stock_name": "Astrazeneca Phar",
    "full_name": "Astrazeneca Pharma India Ltd",
    "name_url": "stocks-analysis/astrazeneca-phar",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "9,115.00",
    "chg": -73.9,
    "chgp": "-0.8%",
    "dir": -1,
    "prev_price": "9,188.90",
    "mcapval": "22,770.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 506820,
    "symbol": "ASTRAZEN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE203A01020",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "987 ",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/astrazeneca-phar-777011-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MN",
      "url": "https://www.marketsmojo.com/mojopro/strategy/2",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/astrazeneca-phar-777011-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "777011",
    "stock_news_url": "https://www.marketsmojo.com/news/astrazeneca-pharma-india-777011"
  },
  "announcements": [
    {
      "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "27-Nov-2025",
      "details": "Please find the enclosed intimation of the Company as per the captioned subject for your reference.",
      "source": "BSE"
    },
    {
      "caption": "Information Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "18-Nov-2025",
      "details": "Please find the enclosed intimation of the Company as per the captioned subject.",
      "source": "BSE"
    },
    {
      "caption": "Intimation About Second Brand Partnership Between Astrazeneca Pharma India Limited (Company) And Sun Pharmaceuticals Industries Limited For Sodium Zirconium Cyclosilicate Powder For Oral Suspension 5 G",
      "datetime": "17-Nov-2025",
      "details": "Please find the enclosed intimation of the Company in relation to the captioned subject for your reference.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Astrazeneca Pharma India Ltd has declared <strong>1600%</strong> dividend, ex-date: 18 Jul 25",
          "dt": "2025-07-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Astrazeneca Pharma India Ltd has announced <strong>2:10</strong> stock split, ex-date: 15 Jun 06",
          "dt": "2006-06-15",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

27-Nov-2025 | Source : BSE

Please find the enclosed intimation of the Company as per the captioned subject for your reference.

Information Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

18-Nov-2025 | Source : BSE

Please find the enclosed intimation of the Company as per the captioned subject.

Intimation About Second Brand Partnership Between Astrazeneca Pharma India Limited (Company) And Sun Pharmaceuticals Industries Limited For Sodium Zirconium Cyclosilicate Powder For Oral Suspension 5 G

17-Nov-2025 | Source : BSE

Please find the enclosed intimation of the Company in relation to the captioned subject for your reference.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Astrazeneca Pharma India Ltd has declared 1600% dividend, ex-date: 18 Jul 25

stock-summary
SPLITS

Astrazeneca Pharma India Ltd has announced 2:10 stock split, ex-date: 15 Jun 06

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available